Company profile
Hepion Pharmaceuticals, Inc. CIK 1583771
Tickers
CTRVP (OTC) · HEPA (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Red Bank, NJ 07701
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$8.28M
Total assets
$3.07M
Total liabilities
$402.4K
Stockholders' equity
$2.67M
Cash & equivalents
$1.83M
Operating income
-$4.16M
Operating cash flow
-$3.27M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
13.1%
Equity / assets
86.9%
CapEx / revenue
—
Operating cash flow / net income
0.40×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$8.28M
$3.07M
$402.4K
$2.67M
2024
—
-$13.19M
$1.61M
$3.48M
-$1.86M
2023
$0
-$48.93M
$18.09M
$10.81M
$7.28M
2022
$0
-$42.20M
$60.24M
$10.39M
$49.86M
2021
$0
-$32.72M
$103.55M
$10.56M
$93.00M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 3
2026-09-16
Financials filed via
Form 10-K
filed 2026-03-12
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Red Bank, NJ 07701
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.